Cargando…

COVID-19 Vaccination in Patients With Membranous Nephropathy

Detalles Bibliográficos
Autores principales:	Visch, Ruben, Wetzels, Jack, Vink, Coralien, van de Logt, Anne-Els
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181366/ https://www.ncbi.nlm.nih.gov/pubmed/35702396 http://dx.doi.org/10.1016/j.ekir.2022.05.038

Ejemplares similares

Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy
por: Vink, Coralien H., et al.
Publicado: (2022)

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
por: Logt, Anne-Els van de, et al.
Publicado: (2021)

Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study
por: van de Logt, Anne-Els, et al.
Publicado: (2015)

Membranous nephropathy following anti–COVID-19 mRNA vaccination
por: Gueguen, Lorraine, et al.
Publicado: (2021)

COVID-19 vaccination and Atypical hemolytic uremic syndrome
por: Bouwmeester, Romy N., et al.
Publicado: (2022)

A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19
por: Da, Yi, et al.
Publicado: (2021)

IgA nephropathy following COVID-19 vaccination: challenges and perspectives
por: Niel, Olivier, et al.
Publicado: (2022)

Membranous nephropathy and carbamazepine
por: Sangeetha, B., et al.
Publicado: (2014)

IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine
por: Hanna, Christian, et al.
Publicado: (2021)

Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy
por: Kudose, Satoru, et al.
Publicado: (2021)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

D-penicillamine-induced membranous nephropathy
por: Kumar, R. P. Senthil, et al.
Publicado: (2014)

Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013)

Membranous Nephropathy with Collapse: Poor Prognosis
por: Bharati, Joyita, et al.
Publicado: (2020)

Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
por: Leong, Leanne Ca-Yin, et al.
Publicado: (2021)

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021)

Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination
por: Plasse, Richard, et al.
Publicado: (2021)

The immunohistological profile of membranous nephropathy associated with syphilis infection
por: Wanderley, David Campos, et al.
Publicado: (2021)

Crescentic Glomerulonephritis and Membranous Nephropathy: An Unusual Association
por: Zajjari, Y., et al.
Publicado: (2019)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Early Recurrent Primary Membranous Nephropathy Detected in an Allograft Biopsy
por: Kaur, T., et al.
Publicado: (2019)

IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine
por: Niel, Olivier, et al.
Publicado: (2021)

Macroscopic hematuria in two children with IgA nephropathy remission following Pfizer COVID-19 vaccination
por: Udagawa, Tomohiro, et al.
Publicado: (2022)

Renal outcomes in immunoglobulin A nephropathy following COVID-19 vaccination: a retrospective cohort study
por: Lim, Ru Sin, et al.
Publicado: (2022)

IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine
por: Abdel-Qader, Derar H., et al.
Publicado: (2022)

Two patients presenting IgA nephropathy after COVID-19 vaccination during a follow-up for asymptomatic hematuria
por: Morisawa, Kazumi, et al.
Publicado: (2022)

Membranous nephropathy associated with the use of levodopa-carbidopa combination
por: Chaitanya, V., et al.
Publicado: (2015)

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia
por: Izzedine, Hassan, et al.
Publicado: (2022)

Mucous Membrane Pemphigoid Following the Administration of COVID-19 Vaccine
por: Rungraungrayabkul, Dulyapong, et al.
Publicado: (2023)

Antiglomerular Basement Membrane Disease Combined with IgA Nephropathy
por: Gupta, Yashita, et al.
Publicado: (2019)

In reply to “Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters”
por: Imai, Hirokazu, et al.
Publicado: (2016)

Thin basement membrane nephropathy: is there genetic predisposition to more severe disease?
por: Deltas, Constantinos
Publicado: (2009)

Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy
por: Mao, Xia, et al.
Publicado: (2023)

A case of membranous immunotactoid glomerulopathy misdiagnosed as membranous nephropathy: significance of electron microscopy in kidney biopsy
por: Feng, Yunlin, et al.
Publicado: (2023)

A rare case of membranous nephropathy associated with chronic inflammatory demyelinating polyradiculoneuropathy
por: Zhang, Qiong, et al.
Publicado: (2023)

COVID-19: impact of vaccination in myeloma patients
por: Hoornaert, E., et al.
Publicado: (2022)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

COVID‐19‐vaccinated plasma treatment for COVID‐19 patients?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2021)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy
por: Suzuki, Tomo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sa3bojnebase3qqicb2iob6dlt